Sleep apnea linked to brain changes: Individuals with breathing issues during sleep may have an enlarged hippocampus, responsible for memory and thinking, and alterations in the brain's white matter, a common sign of reduced brain health associated with aging

Read Full Article

#SleepApnea #BrainHealth #MemoryLoss #Neuroscience #AgingResearch

Medical conditions that deprive testes of oxygen, like sleep apnoea, may be contributing to decline in male fertility over past 50 years, study suggests. High-altitude activities like hiking can also cause lack of oxygen in testis - fertility effects are temporary but take a few months to reverse.

Read Full Article

#MaleFertility #SleepApnea #HighAltitude #HealthResearch #TesticularHealth

Researcher figures out how to diagnose people with sleep apnea while they’re awake using EEGs

Read Full Article

#SleepApnea #HealthInnovation #EEGTechnology #SleepResearch #AwakeDiagnosis

Low oxygen levels from obstructive sleep apnea 💤, especially during REM sleep 🌙, may be linked to cognitive decline 🧠 due to damage to the small blood vessels in the brain 🩸 and the downstream impact of this damage on parts of the brain associated with memory 🕰️.

Read Full Article

#SleepApnea #CognitiveDecline #REMsleep #HealthAwareness #BrainHealth

Sleep apnea cases to rise 45% 🌍 and one global factor is to blame | Researchers found a link between new cases of sleep apnea and climate change 🌡️, which is on trend with many chronic conditions and diseases expected to be more prevalent as temperatures change.

Read Full Article

#SleepApnea #ClimateChange #HealthTrends #ChronicIllness #PublicHealth

💊 A new pill, AD109, shows promise in controlling obstructive sleep apnea (OSA) by targeting its root causes, unlike current standard treatments.

🔬 The phase 3 SynAIRgy trial, involving 646 patients who couldn't tolerate CPAP, found AD109 reduced breathing interruptions by 44% and improved oxygen levels.

📈 Over 40% of patients saw their OSA severity improve, with 18% achieving complete control. The drug, a combination of aroxybutynin and atomoxetine, has an acceptable safety profile, with mild side effects.

🚀 AD109 has received FDA Fast Track designation, and its developer, Apnimed, expects a potential FDA review date in Q1 2027.

#SleepApnea #MedicalBreakthrough #HealthTech

GLP-1 drugs may improve obstructive sleep apnea through mechanisms beyond weight loss, including effects on breathing control, upper-airway neuromuscular function, and inflammation

Read Full Article

#GLP1 #SleepApnea #ObstructiveSleepApnea